Modulation of visual cortex excitability in migraine with aura: Effects of valproate therapy

Neuroscience Letters

Volumn 467, Issue 1, 2009, Pages 26-29

  Palermo, Antonio ^a   Fierro, Brigida ^a   Giglia, Giuseppe ^a   Cosentino, Giuseppe ^a   Puma, Angela Rita ^a   Brighina, Filippo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Phosphene threshold; rTMS; Valproate

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; HUMAN; MALE; MIGRAINE WITH AURA; NERVE CELL EXCITABILITY; NEUROMODULATION; OCCIPITAL CORTEX; PATIENT ASSESSMENT; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION; VISUAL CORTEX; VISUAL STIMULATION; VISUAL THRESHOLD;

ADULT; ANALYSIS OF VARIANCE; FEMALE; GABA AGENTS; HUMANS; MALE; MIDDLE AGED; MIGRAINE WITH AURA; PHOSPHENES; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION; VALPROIC ACID; VISUAL CORTEX; YOUNG ADULT;

EID: 70350341779     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.09.054     Document Type: Article

References (37)

1. Amassian V.E., Cracco R.Q., Maccabee P.J., Cracco J.B., Rudell A.P., and Eberle L. Transcranial magnetic stimulation in study of the visual pathway. J Clin Neurophysiol 15 (1998) 288-304
2. Artemenko A.R., Kurenkov A.L., Filatova E.G., Nikitin S.S., Kaube H., and Katsarava Z. Effects of topiramate on migraine frequency and cortical excitability in patients with frequent migraine. Cephalalgia 28 (2008) 203-208
3. Aurora S.K., al-Sayeed F., and Welch K.M. The cortical silent period is shortened in migraine with aura. Cephalalgia 19 (1999) 708-712
4. Bialer M., and Yagen B. Valproic acid: second generation. Neurotherapeutics 4 (2007) 130-137
5. Bohotin V., Fumal A., Vandenheede M., Gérard P., Bohotin C., Maertens de Noordhout A., and Schoenen J. Effects of repetitive transcranial magnetic stimulation on visual evoked potentials in migraine. Brain 125 (2002) 912-922
6. Boroojerdi B., Prager A., Muellbacher W., and Cohen L.G. Reduction of human visual cortex excitability using 1 Hz transcranial magnetic stimulation. Neurology 54 (2000) 1529-1531
7. Brighina F., Piazza A., Daniele O., and Fierro B. Modulation of visual cortex excitability in migraine with aura: effects of 1 Hz repetitive transcranial magnetic stimulation. Exp Brain Res 145 (2002) 177-181
8. Brighina F., Giglia G., Scalia S., Francolini M., Palermo A., and Fierro B. Facilitatory effects of 1 Hz rTMS in motor cortex of patients affected by migraine with aura. Exp Brain Res 161 (2005) 34-38
9. Cantello R., Civardi C., Varrasi C., Vicentini R., Cecchin M., Boccagni C., and Monaco F. Excitability of the human epileptic cortex after chronic valproate: a reappraisal. Brain Res 1099 (2006) 160-166
10. Chadaide Z., Arlt S., Antal A., Nitsche M.A., Lang N., and Paulus W. Transcranial direct current stimulation reveals inhibitory deficiency in migraine. Cephalalgia 27 (2007) 833-839
11. Curra A., Pierelli F., Coppola G., Barbanti P., Buzzi M.G., Galeotti F., Serrao M., Truini A., Casal C., Pauri F., and Cruccu G. Shortened cortical silent period in facial muscles of patients with migraine. Pain 132 (2007) 124-131
12. + pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33 (2003) 192-196
13. de Tommaso M., Guido M., Sardaro M., Serpino C., Vecchio E., De Stefano G., Di Claudio T., Specchio L.M., and Livrea P. Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. Neurosci Lett 442 (2008) 81-85
14. Dichgans M., Freilinger T., Eckstein G., Babini E., Lorenz-Depiereux B., Biskup S., Ferrari M.D., Herzog J., van den Maagdenberg A.M., Pusch M., and Strom T.M. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366 9483 (2005) 371-377
15. Evers S. Treatment of migraine with prophylactic drugs. Expert Opin Pharmacother 9 (2008) 2565-2573 [Review]
16. Evers S., Afra J., Frese A., Goadsby P.J., Linde M., May A., and Sándor P.S. EFNS guideline on the drug treatment of migraine-report of an EFNS task force. Eur J Neurol 13 (2006) 560-572
17. Fierro B., Brighina F., Vitello G., Piazza A., Scalia S., Giglia G., Daniele O., and Pascual-Leone A. Modulatory effects of low- and high-frequency rTMS on visual cortex of healthy subjects undergoing light deprivation. J Physiol 565 (2005) 659-665
18. Galeotti N., Ghelardini C., Zoppi M., Del Bene E., Raimondi L., Beneforti E., and Bartolini A. Hypofunctionality of Gi proteins as aetiopathogenic mechanism for migraine and cluster headache. Cephalalgia 21 (2001) 38-45
19. Gobbi G., and Janiri L. Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex. Psychopharmacology (Berl) 185 (2006) 255-262
20. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 24 Suppl. 1 (2004) 9-160
21. Houghton B.L., and Bowers J.B. Valproic acid overdose: a case report and review of therapy. MedGenMed 5 (2003) 5
22. Johannessen C.U. Mechanisms of action of valproate: a commentatory. Neurochem Int 37 (2000) 103-110
23. Kazis D.A., Kimiskidis V.K., Papagiannopoulos S., Sotirakoglou K., Divanoglou D., Vlaikidis N., Mills K.R., and Kazis A. The effect of valproate on silent period and corticomotor excitability. Epileptic Disord 8 (2006) 136-142
24. Kruger H., Luhmann H.J., and Heinemann U. Repetitive spreading depression causes selective suppression of GABA-ergic function. Neuroreport 7 (1996) 2733-2736
25. Li X., Ricci R., Large C.H., Anderson B., Nahas Z., and Gorge M.S. Lamotrigine and valproic acid have different effects on motorcortical neuronal excitability. J Neural Transm (2009) [Published on line: 24 February]
26. Mulleners W.M., Chronicle E.P., Palmer J.E., Koehler P.J., and Vredeveld J.W. Suppression of perception in migraine: evidence for reduced inhibition in visual cortex. Neurology 56 (2001) 178-183
27. Mulleners W.M., Chronicle E.P., Vredeveldb J.W., and Koehlera P.J. Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS. Eur J Neurol 9 (2002) 35-40
28. 2+ channel gene CACNL1A4. Cell 87 (1996) 543-552
29. Palmer J.E., Chronicle E.P., Rolan P., and Mulleners W.M. Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients. Cephalalgia 20 (2000) 525-532
30. Pascual-Leone A., Valls-Sole J., Wassermann E.M., and Hallett M. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 117 (1994) 847-858
31. Pascual-Leone A., Tormos J.M., Keenan J., and Catala M.D. Study and modulation of cortical excitability by repetitive transcranial magnetic stimulation. J Clin Neurophysiol 15 (1998) 333-343
32. Salako S.E. The declaration of Helsinki 2000: ethical principles and the dignity of Verence. Med Law 25 (2006) 341-354
33. Sloper J.J., Johnson P., and Powell T.P.S. Selective degeneration of interneurons in the motor cortex of infant monkey following controlled hypoxia: a possible cause of epilepsy. Brain Res 198 (1980) 204-209
34. Smith M.J., Adams L.F., Schmidt P.J., Rubinow D.R., and Wassermann E.M. Effects of ovarian hormones on human cortical excitability. Ann Neurol 51 (2002) 599-603
35. Vollono C., Ferraro D., Miliucci R., Vigevano F., and Valeriani M. The abnormal recovery cycle of somatosensory evoked potential components in children with migraine can be reversed by topiramate. Cephalalgia (2009) [June 1, Epub ahead of print]
36. Werhahn K.J., Kunesch E., Noachtar S., Benecke R., and Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol 517 Pt 2 (1999) 591-597
37. Ziemann U., Lonnecker S., Steinhoff B.J., and Paulus W. Motor excitability changes under antiepileptic drugs. Adv Neurol 81 (1999) 291-298